Iovance Biotherapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| MHR FUND MANAGEMENT LLC | 11/14/2025 | 28.97 M | $62.86 M | 0.00% | 8.66% |
| BLACKROCK, INC. | 11/12/2025 | 25.96 M | $56.33 M | 11.70% | 7.76% |
| VANGUARD GROUP INC | 11/07/2025 | 24.06 M | $52.21 M | -4.06% | 7.19% |
| STATE STREET CORP | 11/14/2025 | 13.31 M | $28.88 M | 34.57% | 3.98% |
| INVENOMIC CAPITAL MANAGEMENT LP | 11/14/2025 | 10.54 M | $22.88 M | 27.09% | 3.15% |
| LONG FOCUS CAPITAL MANAGEMENT, LLC | 11/14/2025 | 9.12 M | $19.78 M | -22.87% | 2.73% |
| PALO ALTO INVESTORS LP | 11/14/2025 | 7.62 M | $16.53 M | 122.15% | 2.28% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2025 | 6.87 M | $14.91 M | 10.97% | 2.05% |
| GOLDMAN SACHS GROUP INC | 11/14/2025 | 6.58 M | $14.27 M | 38.44% | 1.97% |
| BANK OF AMERICA CORP /DE/ | 11/14/2025 | 6.28 M | $13.63 M | 55.83% | 1.88% |
| MORGAN STANLEY | 11/14/2025 | 5.58 M | $12.11 M | -13.48% | 1.67% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2025 | 4.41 M | $9.58 M | -52.70% | 1.32% |
| CITADEL ADVISORS LLC | 11/14/2025 | 3.82 M | $8.29 M | -7.13% | 1.14% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2025 | 3.31 M | $7.18 M | 59.62% | 0.99% |
| PRINCIPAL FINANCIAL GROUP INC | 11/04/2025 | 3.01 M | $6.54 M | -34.50% | 0.90% |
| DIMENSIONAL FUND ADVISORS LP | 11/12/2025 | 2.82 M | $6.13 M | -3.62% | 0.84% |
| TWO SIGMA INVESTMENTS, LP | 11/14/2025 | 2.74 M | $5.95 M | -40.85% | 0.82% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/10/2025 | 2.50 M | $5.43 M | 30.68% | 0.75% |
| NORTHERN TRUST CORP | 11/14/2025 | 2.46 M | $5.34 M | 16.10% | 0.74% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 11/14/2025 | 2.06 M | $4.47 M | -2.66% | 0.62% |
| ORION INVESTMENT CO | 11/13/2025 | 1.85 M | $4.02 M | -20.82% | 0.55% |
| ROYAL BANK OF CANADA | 11/14/2025 | 1.55 M | $3.38 M | -34.65% | 0.46% |
| WELLS FARGO & COMPANY/MN | 11/13/2025 | 1.52 M | $3.29 M | 41.25% | 0.45% |
| B GROUP, INC. | 11/14/2025 | 1.50 M | $3.26 M | 0.00% | 0.45% |
| RICE HALL JAMES & ASSOCIATES, LLC | 10/16/2025 | 1.45 M | $3.15 M | -8.81% | 0.43% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2025 | 1.44 M | $3.11 M | 278.48% | 0.43% |
| JANE STREET GROUP, LLC | 11/14/2025 | 1.41 M | $3.07 M | -29.58% | 0.42% |
| C WORLDWIDE GROUP HOLDING A/S | 11/05/2025 | 1.26 M | $2.73 M | 0.00% | 0.38% |
| NUVEEN, LLC | 11/12/2025 | 1.25 M | $2.72 M | 60.70% | 0.37% |
| JPMORGAN CHASE & CO | 11/26/2025 | 1.22 M | $2.66 M | -1.53% | 0.37% |
| RHENMAN & PARTNERS ASSET MANAGEMENT AB | 11/13/2025 | 1.10 M | $2.38 M | 69.46% | 0.33% |
| TWO SIGMA ADVISERS, LP | 11/14/2025 | 1.06 M | $2.30 M | -54.64% | 0.32% |
| SOLEUS CAPITAL MANAGEMENT, L.P. | 11/14/2025 | 976.71 K | $2.12 M | -70.06% | 0.29% |
| INVESCO LTD. | 11/13/2025 | 945.47 K | $2.05 M | 44.58% | 0.28% |
| BARCLAYS PLC | 11/12/2025 | 936.69 K | $2.03 M | 5.92% | 0.28% |
| UBS GROUP AG | 11/13/2025 | 936.50 K | $2.03 M | -47.37% | 0.28% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2025 | 920.20 K | $2.00 M | 89.54% | 0.28% |
| SUSQUEHANNA PORTFOLIO STRATEGIES, LLC | 11/14/2025 | 912.10 K | $1.98 M | 100.00% | 0.27% |
| BANK OF NEW YORK MELLON CORP | 11/03/2025 | 807.18 K | $1.75 M | 3.40% | 0.24% |
| CM MANAGEMENT, LLC | 11/13/2025 | 700.00 K | $1.52 M | 0.00% | 0.21% |
| QVT FINANCIAL LP | 11/14/2025 | 678.56 K | $1.47 M | 0.00% | 0.20% |
| VOSS CAPITAL, LLC | 11/20/2025 | 650.00 K | $1.41 M | -3.36% | 0.19% |
| CITADEL ADVISORS LLC | 11/14/2025 | 647.20 K | $1.40 M | 12.13% | 0.19% |
| DEUTSCHE BANK AG\ | 11/13/2025 | 645.46 K | $1.40 M | 4.03% | 0.19% |
| LPL FINANCIAL LLC | 11/12/2025 | 611.40 K | $1.33 M | 26.24% | 0.18% |
| ABRDN PLC | 11/07/2025 | 607.21 K | $1.32 M | 17.61% | 0.18% |
| CITADEL ADVISORS LLC | 11/14/2025 | 583.10 K | $1.27 M | 35.79% | 0.17% |
| WOODLINE PARTNERS LP | 11/14/2025 | 567.68 K | $1.23 M | 0.00% | 0.17% |
| HENNION & WALSH ASSET MANAGEMENT, INC. | 10/22/2025 | 544.35 K | $1.18 M | 9.03% | 0.16% |
| TANG CAPITAL MANAGEMENT LLC | 11/14/2025 | 543.76 K | $1.18 M | -69.79% | 0.16% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Iovance Biotherapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 355 institutional investors and hedge funds held shares of Iovance Biotherapeutics, Inc.. The most heavily invested institutionals were:
MHR FUND MANAGEMENT LLC: 28.97 M
BlackRock, Inc.: 25.96 M
VANGUARD GROUP INC: 24.06 M
STATE STREET CORP: 13.31 M
Invenomic Capital Management LP: 10.54 M
Long Focus Capital Management, LLC: 9.12 M
63.65% of Iovance Biotherapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 248.58 M shares in the last 24 months. This purchase volume represents approximately $581.69 M in transactions.